Navigation Links
Simcere Pharmaceutical Group Reports Third Quarter 2007 Results
Date:11/5/2007

CONSOLIDATED Balance Sheets

(UNAUDITED, Amounts expressed IN THOUSANDS)

December 31, September 30, September 30,

2006 2007 2007

RMB RMB USD

Assets

Current assets

Cash and cash equivalents 106,027 684,016 91,290

Pledged bank deposits 20,787 1,070 143

Short term investments -- 450,000 60,058

Accounts receivable, net of

allowance for

doubtful accounts 61,723 126,087 16,828

Bills receivable 101,058 258,477 34,496

Inventories 39,483 45,421 6,062

Prepaid expenses and other

current assets 79,192 20,615 2,751

Amounts due from related

parties 434 10,616 1,417

Deferred income taxes 2,725 -- --

Total current assets 411,429 1,596,302 213,045

Property, plant and

equipment, less

accumulated depreciation 267,054 287,624 38,387

Land use rights 82,522 96,351 12,859

Deposits for purchase of

property, plant and

equipment 4,056 1,625 217

Intangible assets, net 163,148 173,170 23,111

Goodwill 100,634 105,086 14,025

Deferred income taxes 5,704 5,614 749

Total assets 1,034,547 2,265,772 302,393

Liabilities

Current liabilities

Short-term bank loans and


'/>"/>
SOURCE Simcere Pharmaceutical Group
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related medicine news :

1. Simcere Pharmaceutical Group Acquires a 51% Stake in Boda Pharmaceutical Co., Ltd.
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
6. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
7. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
8. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
9. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
10. Par Pharmaceutical Files Form 10-K for 2006 -- Company to Hold First Analysts Meeting September 28, 2007
11. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/14/2008)... Also debuts TMR,09 campaign, IRVINE, Calif., O...poration (Pink Sheets: CGCP), a global leader of i...nd the market leader of surgical products for,tran...educational symposium,yesterday in conjunction wit...rapeutics (TCT) meeting in Washington, D.C., The ...
(Date:10/14/2008)... more than 500 accounts Company opening new PROMUS...ICK, Mass., Oct. 14 /PRNewswire-FirstCall/ -- Bost...unced estimated U.S. market shares for,September f...liminary data,from Millennium Research Group (MRG)...he healthcare sector., Based on the MRG data, the...
(Date:10/14/2008)... Leading Supplemental Insurance Company Encour... Employee Benefits , Chic...e , a leading provider of supplemental insurance, ...time to review employee benefits and recommends ,V...to help retain employees. These programs can be a ...
(Date:10/14/2008)...ctober 14 /PRNewswire/ -- Researchers at the Insti... started work on a 3.5 year,project to develop a n...hemical vapour deposition) diamond manufactured by...he field of CVD diamond synthesis and its,applicat...uld open up a raft of new,application areas in, fo...
Breaking Medicine News(10 mins):Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 2Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 3Health News:Cardiogenesis Announces Successful Educational Symposium Targeted at Cardiologists at the TCT Meeting in Washington, D.C. 4Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 2Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 3Health News:Boston Scientific Announces Drug-Eluting Stent Market Share Estimates for September and Third Quarter 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 2Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 3Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 4Health News:Combined Insurance Reports that Voluntary Programs Can Offer Employers a Cost Effective Way to Offer Benefits and Help Retain Employees 5Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 2Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 3Health News:Novel Solid-State Laser Design Based on Synthetic Diamond From Element Six Opens up New Applications 4
...fter receiving organ transplants from a single don...ralia. Upon examination of tissue samples the caus... in the victims’ bodies. The virus was traced in...ourne who died in the few weeks following the tran...
...that had been sweeping across Orissa for the past ...e result of the soaring temperature which// has cr..., officials said. The western town of Sundergarh ...he western towns of Bhabanipatna, Bolangir and the...
...etables are the most preferred by children and the...hers interviewed parents of 1,658 children aged tw... them about their family's diet, including homegro... The study, published in April's journal of the Am...
...onal Development Secretary Hilary Benn on Wednesda...cines// Transparency Alliance -- an initiative tha...including HIV/AIDS, tuberculosis and malaria treat...inancial Times reports. MeTA aims to improve acc...
Other Medicine News:
(Date:10/13/2008)...re/ -- Neuronascent, Inc.,( http://www.neuronascen...ved,funding from multiple sources to further the d...eting Alzheimer,s disease, depression and,ischemia...m Maryland,Department of Business and Economic Dev...dustrial Partnerships in collaboration with Univer...
(Date:10/13/2008)...re/ -- Facet Solutions, Inc. today,announced the c... its US,IDE Pilot Study. The results show a 78% re... and an 80% reduction in Visual Analog Scores (VAS... & CEO for Facet Solutions,added, "We are very pl...,only demonstrate significant pain relief but the ...
(Date:10/10/2008)...swire/ -- Diplomat Specialty,Pharmacy announced to...pecialty Pharmacy to be one of only three sites to...timization Study for Multiple Sclerosis (TOP MS).,...amine the benefits of a,specialty pharmacy therapy...atient outcomes. Targeted patient outcomes will in...
(Date:10/9/2008)...wareness and Bring Hope to Millions,of Children in... -- 133 million children,across the globe are with...saster, civil war, and disease. SOS Children,s Vil... by calling attention to the needs of orphans,worl...o:, http://www.prnewswire.com/mnr/soschildrensvi...
Breaking Medicine Technology:Neuronascent, Inc. Receives Multiple Fundings for Its Neurogenesis Therapeutic Programs 2Diplomat Specialty Pharmacy Tapped by Teva Neuroscience for Therapy Optimization Study for Multiple Sclerosis (TOP MS) 2Photos: SOS Children's Villages Observes World Orphan Week, October 5-11, 2008 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 1152 1University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 1152 2University HealthSystem Consortium Chooses SciQuest to Optimize Medical Research Procurement 1152 3Virtual game helps children escape realities of burn unit 3211 1Virtual game helps children escape realities of burn unit 3211 2Professor Sir Martin Evans wins Nobel Prize for Medicine 726 1Professor Sir Martin Evans wins Nobel Prize for Medicine 726 2Nursesavvy com Promoting Quality Healthcare for Everyone 3206 1Nursesavvy com Promoting Quality Healthcare for Everyone 3206 2
...007 /PRNewswire-FirstCall/ -- ZymoGenetics,Inc. t...d from a,Phase 1b clinical trial with atacicept in...e American Society of Clinical,Oncology (ASCO) 200...dministration of higher doses than had been tested...as well-tolerated and biologically,active at all d...
...SINESS WIRE)--Jun 4, 2007 - Acorda,Therapeutics, I...pany presented a "meta-analysis" or combined analy...tiple sclerosis during a,poster session at the Ame...ACTRIMS) Meeting in Washington, D.C. on Saturday, ...t Improvement in Walking,Speed on the Timed 25 Foo...
Other Medicine Technology:ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 2ZymoGenetics Reports Results From Atacicept Phase 1b Clinical Trial,in B-Cell Chronic Lymphocytic Leukemia 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 2Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 3Acorda Therapeutics Presents Fampridine-SR Data at ACTRIMS Meeting 4
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
...e; is a 1-step, hand-held, point-of-care device fo...lites in human urine. The TOX/See device can dete... 3 to 8 minutes and requires only a few drops of u...ed to maximize convenience and ease of use. TOX/Se...
Sugar-Chex Linearity is a whole blood formulation designed to cover the linear reportable range of the most popular glucose meters. The product meets CAP recommendations of using a control matrix tha
Medicine Products: